Clicky

Merck & Company Inc(MRK) News

Date Title
May 5 Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now?
May 1 Merck & Co., Inc. (MRK): Jim Cramer Agrees – “Merck’s A Good Company”
May 1 Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
May 1 Top Dividend Stocks To Consider In May 2025
Apr 30 Is Merck & Co. Inc. (MRK) the Best Dow Stock for the Next 12 Months?
Apr 30 Merck & Co., Inc. (MRK): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential
Apr 30 Construction begins on MSD’s $1bn biologics centre in Delaware, US
Apr 29 How To Put $100 In Your Retirement Fund Each Month With Merck Stock
Apr 29 Pfizer offers 'longer-term' opportunity amid tariff uncertainty
Apr 29 Is Merck & Co., Inc. (MRK) the Worst-Performing Blue Chip Stock So Far in 2025?
Apr 29 Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware
Apr 29 Merck to Spend $1 Billion on New Factory to Make U.S. Supplies of Blockbuster Drug
Feb 17 Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?
Feb 15 Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes
Feb 13 Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
Feb 13 Merck & Co., Inc. (MRK): A Bull Case Theory
Feb 13 US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
Feb 12 Why Merck & Co., Inc. (MRK) is Declining
Feb 11 Jim Cramer on Merck & Co., Inc. (MRK): ‘Drug Stocks Are Really Getting Hurt’
Feb 11 Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant trea...